As of July 2025 Milestone Pharmaceuticals has a market cap of NZ$0.22 Billion. This makes Milestone Pharmaceuticals the world's 9025th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Marketcap | Change |
---|---|---|
2025 | NZ$0.22 B | 8.47% |
2024 | NZ$0.20 B | 129.92% |
2023 | NZ$88.41 M | -58.65% |
2022 | NZ$0.21 B | -25.35% |
2021 | NZ$0.28 B | 3.44% |
2020 | NZ$0.27 B | -52.44% |
2019 | NZ$0.58 B |
On Jul 28th, 2025 the market cap of Milestone Pharmaceuticals was reported to be:
Name | Marketcap | Market cap differencediff. | Country |
---|---|---|---|
![]() ORIC Pharmaceuticals
ORIC | NZ$1.63 B | 640.27% | ๐บ๐ธ USA |